BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 26079613)

  • 1. Enhanced neutralising antibody response to bovine viral diarrhoea virus (BVDV) induced by DNA vaccination in calves.
    R El-Attar LM; Thomas C; Luke J; A Williams J; Brownlie J
    Vaccine; 2015 Jul; 33(32):4004-12. PubMed ID: 26079613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune responses to non-structural protein 3 (NS3) of bovine viral diarrhoea virus (BVDV) in NS3 DNA vaccinated and naturally infected cattle.
    Young NJ; Thomas CJ; Thompson I; Collins ME; Brownlie J
    Prev Vet Med; 2005 Nov; 72(1-2):115-20; discussion 215-9. PubMed ID: 16169103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the induction of NS3 specific BVDV antibodies using a commercial inactivated BVDV vaccine in immunization and challenge trials.
    Makoschey B; Sonnemans D; Bielsa JM; Franken P; Mars M; Santos L; Alvarez M
    Vaccine; 2007 Aug; 25(32):6140-5. PubMed ID: 17336433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequence-optimised E2 constructs from BVDV-1b and BVDV-2 for DNA immunisation in cattle.
    Couvreur B; Letellier C; Olivier F; Dehan P; Elouahabi A; Vandenbranden M; Ruysschaert JM; Hamers C; Pastoret PP; Kerkhofs P
    Vet Res; 2007; 38(6):819-34. PubMed ID: 17727807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of long-term antibody responses to two inactivated bovine viral diarrhoea virus (BVDV) vaccines.
    González AM; Arnaiz I; Yus E; Eiras C; Sanjuán M; Diéguez FJ
    Vet J; 2014 Mar; 199(3):424-8. PubMed ID: 24461201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of an APC-targeted multivalent E2-based vaccine against Bovine Viral Diarrhea Virus types 1 and 2.
    Pecora A; Malacari DA; Perez Aguirreburualde MS; Bellido D; Nuñez MC; Dus Santos MJ; Escribano JM; Wigdorovitz A
    Vaccine; 2015 Sep; 33(39):5163-71. PubMed ID: 26279338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of three inactivated bovine viral diarrhoea virus vaccines on bulk milk p80 (NS3) ELISA test results in dairy herds.
    Sayers RG; Sayers GP; Graham DA; Arkins S
    Vet J; 2015 Jul; 205(1):56-61. PubMed ID: 25986132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic Cell Targeting of Bovine Viral Diarrhea Virus E2 Protein Expressed by
    Wang Y; Feng B; Niu C; Jia S; Sun C; Wang Z; Jiang Y; Cui W; Wang L; Xu Y
    Viruses; 2019 Jun; 11(6):. PubMed ID: 31242608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA prime protein boost strategies protect cattle from bovine viral diarrhea virus type 2 challenge.
    Liang R; van den Hurk JV; Landi A; Lawman Z; Deregt D; Townsend H; Babiuk LA; van Drunen Littel-van den Hurk S
    J Gen Virol; 2008 Feb; 89(Pt 2):453-466. PubMed ID: 18198376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compatibility of plasmids encoding bovine viral diarrhea virus type 1 and type 2 E2 in a single DNA vaccine formulation.
    Liang R; Babiuk LA; van Drunen Littel-van den Hurk S
    Vaccine; 2007 Aug; 25(32):5994-6006. PubMed ID: 17597267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity evaluation of recombinant Lactobacillus casei W56 expressing bovine viral diarrhea virus E2 protein in conjunction with cholera toxin B subunit as an adjuvant.
    Jia S; Huang X; Li H; Zheng D; Wang L; Qiao X; Jiang Y; Cui W; Tang L; Li Y; Xu Y
    Microb Cell Fact; 2020 Oct; 19(1):186. PubMed ID: 33004035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of injectable trace minerals on humoral and cell-mediated immune responses to Bovine viral diarrhea virus, Bovine herpes virus 1 and Bovine respiratory syncytial virus following administration of a modified-live virus vaccine in dairy calves.
    Palomares RA; Hurley DJ; Bittar JH; Saliki JT; Woolums AR; Moliere F; Havenga LJ; Norton NA; Clifton SJ; Sigmund AB; Barber CE; Berger ML; Clark MJ; Fratto MA
    Vet Immunol Immunopathol; 2016 Oct; 178():88-98. PubMed ID: 27496747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of chimeric bovine viral diarrhea viruses containing glycoprotein E rns of heterologous pestiviruses and evaluation of the chimeras as potential marker vaccines against BVDV.
    Luo Y; Yuan Y; Ankenbauer RG; Nelson LD; Witte SB; Jackson JA; Welch SK
    Vaccine; 2012 Jun; 30(26):3843-8. PubMed ID: 22521286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local innate responses and protective immunity after intradermal immunization with bovine viral diarrhea virus E2 protein formulated with a combination adjuvant in cattle.
    Sadat SMA; Snider M; Garg R; Brownlie R; van Drunen Littel-van den Hurk S
    Vaccine; 2017 Jun; 35(27):3466-3473. PubMed ID: 28527686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semiliki forest virus vector carrying the bovine viral diarrhea virus NS3 (p80) cDNA induced immune responses in mice and expressed BVDV protein in mammalian cells.
    Reddy JR; Kwang J; Varthakavi V; Lechtenberg KF; Minocha HC
    Comp Immunol Microbiol Infect Dis; 1999 Oct; 22(4):231-46. PubMed ID: 10465327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of an inactivated Chinese bovine viral diarrhea virus 1a (BVDV 1a) vaccine cross protects from BVDV 1b infection in young calves.
    Wang W; Shi X; Wu Y; Li X; Ji Y; Meng Q; Zhang S; Wu H
    Vet Immunol Immunopathol; 2014 Aug; 160(3-4):288-92. PubMed ID: 24880701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring of BVDV in a vaccinated herd by testing milk for antibodies to NS3 protein.
    Kuijk H; Franken P; Mars MH; bij de Weg W; Makoschey B
    Vet Rec; 2008 Oct; 163(16):482-4. PubMed ID: 18931356
    [No Abstract]   [Full Text] [Related]  

  • 18. Mapping B-cell linear epitopes of NS3 protein of bovine viral diarrhea virus.
    Li Y; Jia Y; Wen K; Liu H; Gao M; Ma B; Zhang W; Wang J
    Vet Immunol Immunopathol; 2013 Feb; 151(3-4):331-6. PubMed ID: 23276751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination of cattle with a DNA plasmid encoding the bovine viral diarrhoea virus major glycoprotein E2.
    Harpin S; Hurley DJ; Mbikay M; Talbot B; Elazhary Y
    J Gen Virol; 1999 Dec; 80 ( Pt 12)():3137-3144. PubMed ID: 10567644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new inactivated BVDV genotype I and II vaccine. An immunisation and challenge study with BVDV genotype I.
    Beer M; Hehnen HR; Wolfmeyer A; Poll G; Kaaden OR; Wolf G
    Vet Microbiol; 2000 Nov; 77(1-2):195-208. PubMed ID: 11042413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.